Impact Factor
2.83
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
1.69
171 total citations
h5-index
19
h5 depth signal
Cited share
64.0%
71 of 111
Total citations
171
Citation footprint
Metric signal
1.43
External metric anchor
Self-citation
5.8%
10 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
Italy
637
China
128
Turkey
52
Egypt
45
France
37
Citing Fields of Research
Oncology
356
Breast Cancer
150
Lung Cancer
149
Palliative Care
77
Liver & Colon Cancer
71
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
8,273
Articles tracked across the journal lifetime
Indexed publication set
111
71 cited publications
Last 12 months
87
7.3 publications/month
Open access share
31.0%
27 OA publications in the last year
Leading citing country
Italy
637 citing publications
Leading citing field
Oncology
356 citing publications
Latest tracked publication
8 October 2026
10 recent records available
Coverage & Indexing History
v51n3, May-Jun. 1965-
v51n3, May-Jun. 1965-
Active Coverage
Active Coverage
Research Focus & Classification
Indexed Subjects
Oncology
Breast Cancer
Lung Cancer
Palliative Care
Genetics & Genomics
Immunology
Issuing & Sponsoring Bodies
Contributor
Istituto nazionale per lo studio e la cura dei tumori (Italy)
Contributor
Società italiana di cancerologia
Contributor
Fondazione Instituto di ricovero e cura a carattere scientifico di natura pubblica
Broad Categories
Neoplasms
Liver & Colon Cancer
Palliative Care
Genetics & Genomics
Breast Cancer
Lung Cancer
Medical Ethics
Immunology
MeSH Descriptors
Neoplasms
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
DOI 10.1177/03008916261490843
Open DOI
Prognostic value of CT-measured baseline tumor volume in nivolumab-treated metastatic renal cell carcinoma
Objective: To evaluate the association between baseline metastatic tumor volume measured on computed tomography (CT) and survival outcomes in patients with metastatic renal cell carcinoma (mRCC) receiving nivolumab as second line or late...
02
DOI 10.1177/03008916261489141
Open DOI
Beyond chemobrain: A stepwise approach to identifying cognitive impairment in non-CNS cancer survivors
Cancer-related cognitive impairment (CRCI) is common in patients with non-central nervous system malignancies, but its identification remains difficult because symptoms are heterogeneous, may predate treatment, and are not captured by a ...
03
DOI 10.1177/03008916261468178
Open DOI
Quality of life in first-line trials for endometrial cancer: A systematic review
Objective: As treatment strategies evolve in advanced or metastatic endometrial cancer (EC), quality of life (QoL) has become a key parameter in evaluating therapeutic value. This systematic review summarizes QoL outcomes from pivotal tr...
04
DOI 10.1177/03008916261478866
Open DOI
Comparison of infusion-related reactions to chemotherapy versus targeted therapy: A four-year experience at the Medical Day Hospital of the Fondazione IRCCS Istituto Nazionale Tumori Milano
Background: Infusion reactions (IRs) are a significant concern in oncology due to unpredictable onset and a lack of standardized management guidelines. Objectives: To compare the incidence, severity and management of IRs related to chemo...
05
DOI 10.1177/03008916261491163
Open DOI
Growth in oncology clinical trials and decline of independent research: Insights from the 22nd AIFA National Report on clinical trials
The 22nd National Report on Clinical Trials of Medicinal Products published by the Italian Medicines Agency (AIFA) in July 2026 highlights contrasting trends in Italian clinical research. In 2024, 669 prospective clinical trials were aut...
06
DOI 10.1177/03008916261478403
Open DOI
Clinical and economic impact of community-based cancer care: Results from the S.M.A.R.T. Care Project in metastatic breast cancer patients
Objectives: To evaluate the clinical and economic impact of shifting from hospital-based to community-based administration of oral, subcutaneous, and intramuscular anticancer therapies for patients with metastatic breast cancer (mBC). Me...
07
DOI 10.1177/03008916261470142
Open DOI
Corrigendum to “Choriocarcinoma: diagnosis, treatment and management of a rare germ cell tumour. An update review”
08
DOI 10.1177/03008916261457067
Open DOI
Composite clinical scores in real-world extensive-stage small-cell lung cancer patients treated with chemo-immunotherapy
Background: Composite scores such as Lung Immune Prognostic Index (LIPI), modified Glasgow Prognostic Score (mGPS), EPSILoN, Pan Immune-Inflammation Value (PIV) and Systemic Immune-Inflammation Index (SII) have shown prognostic value in ...
09
DOI 10.1177/03008916261468121
Open DOI
Reducing the burden of active surveillance monitoring examinations in prostate cancer: Insights from real-world data to inform clinical practice
Background: Active surveillance (AS) is standard for early-stage prostate cancer, though intensive monitoring continues due to concerns about reclassification to Grade Group (GG) ⩾ 2. We hypothesized that simple and inexpensive clinical ...
10
DOI 10.1177/03008916261472659
Open DOI
Survival of carcinoid lung neuroendocrine tumours after surgical resection: A retrospective audit of 633 cases over 26 years
Background: Optimal postoperative follow-up for lung neuroendocrine tumours (L-NET) and surgical resection approaches remain debated. This audit aimed to benchmark long-term outcomes after L-NET surgery at a high-volume centre, identify ...
Bibliographical & Catalog Notes
Issues for Jan. 2015- have title: Tumori journal.
Part of title on microfilm.
Issued 1911-26 in Rome.
Issues for 1927-50 called also ser. 2, v. 1-24.
Also issued online.
Microfilm. v. 1 (1911)-20 (1934). 11 microfilm reels : negative ; 35 mm.
In English, 1977-
Official organ of the Società italiana di cancerologia, genn./febr. 1962-
Issued by: Istituto nazionale per lo studio e la cura dei tumori di Milano, 1927-1995.